The assessment of LH values allowed us to classify hypogonadism for these patients, and we found that 5/19 (26.3%) showed primary hypogonadism and 14/19 (73.7%) had secondary and/or normogonadotropic hypogonadism. This evidence concerns the gene PLOD1 and Hypergonadotropic hypogonadism.